Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases (PM) is considered to be feasible, safe and to improve survival. AIM: To investigate whether an immune response is activated following HIPEC for PM. METHODS: Six patients were enrolled in this study. Peripheral b...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorentini, Giammaria, Sarti, Donatella, Patriti, Alberto, Eugeni, Emilio, Guerra, Francesco, Masedu, Francesco, Mackay, Andrew Reay, Guadagni, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450817/
https://www.ncbi.nlm.nih.gov/pubmed/32874953
http://dx.doi.org/10.5306/wjco.v11.i6.397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450817/
https://www.ncbi.nlm.nih.gov/pubmed/32874953
http://dx.doi.org/10.5306/wjco.v11.i6.397

Ejemplares similares